Global Glycomics Market Size study & Forecast, by Product (Enzymes, Kits, Reagents, Instruments), by Application (Drug discovery & Development, Diagnostics, Others), by End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Bio

Global Glycomics Market Size study & Forecast, by Product (Enzymes, Kits, Reagents, Instruments), by Application (Drug discovery & Development, Diagnostics, Others), by End-Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Biopharmaceutical Companies, CROs) and Regional Analysis, 2023-2030

Global Glycomics Market is valued at approximately USD 1.65 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.6% over the forecast period 2023-2030. Glycomics is the study of glycans, which are saccharides found in all living organisms. The field is focused on understanding their structure, biology, and function, and has gained interest in disease profiling and biological processes. However, the high cost of tools used in glycomics research hinder market growth.

Technological advancements in glycomics instruments have been a major factor driving the global market, along with increasing investments from governments and biotech companies. For example, in July 2020, GlycoNet, received funding of USD 16.3 million to support their research efforts in glycomic research. Moreover, the study of glycomics in disease profiling and biological processes has become increasingly popular, leading to a significant increase in research and development activities in this area. Recently, the Canadian Glycomics Network and BridgeBio Pharma, Inc. joined forces in April 2021 to apply scientific research in glycomics to develop treatments for patients with genetic diseases. However, the complexity and diversity of glycans make their analysis and characterization challenging for the market to propel. Despite all the challenges, the growing number of biotechnology and biopharmaceutical companies can offer opportunities in the glycomics market.

The key regions considered for the Global Glycomics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to increasing research and development activities and government funding programs. Companies are investing in research and development activities, which are expected to propel the growth of glycomics in the region. According to a report by Statista, in 2022, the research and development (R&D) expenditure by some pharmaceutical companies reached around 101 billion U.S. dollars worldwide. Europe is expected to grow significantly over the forecast period. Due to factors such as research infrastructure with the presence of world-class universities and research institutes. In addition, the availability of funding programs and grants for research has allowed biopharmaceutical companies and academic institutions to conduct more extensive glycomics studies in this region.

Major market player included in this report are:
Thermo Fisher Scientific, Inc.
Merck KgaA
Agilent Technologies Inc.
Bruker
New England Biolabs
Shimadzu Corporation
Waters Corporation
Takara Bio Inc
Asparia Glycomics
RayBiotech Life, Inc.

Recent Developments in the Market:
 In September 2021, a team of researchers at the University of California San Diego created a new tool called GlyCompare which allows for the analysis of glycomics datasets using AI and other machine learning techniques. This approach takes into account the shared biosynthetic pathways of glycans in samples, making it a systems-level perception. The ultimate goal of this research is to contribute to the development of breakthroughs in cancer diagnostics.
 In April 2021, BridgeBio Pharma, Inc. and the Canadian Glycomics Network collaborated to translate scientific research in glycomics into potential treatments for patients having genetic diseases.

Global Glycomics Market Report Scope:
 Historical Data – 2020 - 2021
 Base Year for Estimation – 2022
 Forecast period - 2023-2030
 Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
 Segments Covered - Product, Application, End-Use, Region
 Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Enzymes
Kits
Reagents
Instruments

By Application:
Drug Discovery & Development
Diagnostics
Others

By End-Use:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Biopharmaceutical Companies
CROs

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Thermo Fisher Scientific, Inc.
Merck KgaA
Agilent Technologies Inc.
Bruker
New England Biolabs
Shimadzu Corporation
Waters Corporation
Takara Bio Inc
Asparia Glycomics
RayBiotech Life, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.